{
  "DOI": "10.1186/s40246-019-0239-x",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-019-0239-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\u003cjats:title\u003eBackground\u003c/jats:title\u003e\u003cjats:p\u003eObesity—with its increased risk of obesity-associated metabolic diseases—has become one of the greatest public health epidemics of the twenty-first century in affluent countries. To date, there are no ideal drugs for treating obesity. Studies have shown that activation of brown adipose tissue (BAT) can promote energy consumption and inhibit obesity, which makes browning of white adipose tissue (WAT) a potential therapeutic target for obesity. Our objective was to identify genes and molecular pathways associated with WAT and the activation of BAT to WAT browning, by using publicly available data and computational tools; this knowledge might help in targeting relevant signaling pathways for treating obesity and other related metabolic diseases.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eResults\u003c/jats:title\u003e\u003cjats:p\u003eIn this study, we used text mining to find out genes related to brown fat and white fat browning. Combined with biological process and pathway analysis in GeneCodis and protein-protein interaction analysis by using STRING and Cytoscape, a list of high priority target genes was developed. The Human Protein Atlas was used to analyze protein expression. Candidate drugs were derived on the basis of the drug-gene interaction analysis of the final genes. Our study identified 18 genes representing 6 different pathways, targetable by a total of 33 drugs as possible drug treatments. The final list included 18 peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists, 4 beta 3 adrenoceptor (β3-AR) agonists, 1 insulin sensitizer, 3 insulins, 6 lipase clearing factor stimulants and other drugs.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eConclusions\u003c/jats:title\u003e\u003cjats:p\u003eDrug discovery using in silico text mining, pathway, and protein-protein interaction analysis tools may be a method of exploring drugs targeting the activation of brown fat or white fat browning, which provides a basis for the development of novel targeted therapies as potential treatments for obesity and related metabolic diseases.\u003c/jats:p\u003e\u003c/jats:sec\u003e",
  "alternative-id": [
    "239"
  ],
  "article-number": "55",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "12 May 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "25 September 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "7 November 2019"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pan",
      "given": "Yuyan",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-1289-2782",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Liu",
      "given": "Jiaqi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Qi",
      "given": "Fazhi",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        11,
        7
      ]
    ],
    "date-time": "2019-11-07T11:05:56Z",
    "timestamp": 1573124756000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        1,
        27
      ]
    ],
    "date-time": "2021-01-27T22:47:38Z",
    "timestamp": 1611787658000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001809",
      "award": [
        "No. 81802724"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Natural Science Foundation of China"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        27
      ]
    ],
    "date-time": "2024-02-27T17:09:40Z",
    "timestamp": 1709053780127
  },
  "is-referenced-by-count": 8,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2019,
        11,
        7
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2019,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            11,
            7
          ]
        ],
        "date-time": "2019-11-07T00:00:00Z",
        "timestamp": 1573084800000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            11,
            7
          ]
        ],
        "date-time": "2019-11-07T00:00:00Z",
        "timestamp": 1573084800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0239-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-019-0239-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0239-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2019,
        11,
        7
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        11,
        7
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/2327-6924.12510",
      "author": "SM Fruh",
      "doi-asserted-by": "crossref",
      "first-page": "S3",
      "issue": "S1",
      "journal-title": "J Am Assoc Nurse Pract",
      "key": "239_CR1",
      "unstructured": "Fruh SM. Obesity: risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29(S1):S3–S14.",
      "volume": "29",
      "year": "2017"
    },
    {
      "DOI": "10.1001/jamainternmed.2015.2405",
      "author": "L Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1412",
      "issue": "8",
      "journal-title": "JAMA Intern Med",
      "key": "239_CR2",
      "unstructured": "Yang L, Colditz GA. Prevalence of overweight and obesity in the United States, 2007-2012. JAMA Intern Med. 2015;175(8):1412–3.",
      "volume": "175",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ejphar.2015.03.093",
      "author": "KA Martin",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "issue": "Pt A",
      "journal-title": "Eur J Pharmacol",
      "key": "239_CR3",
      "unstructured": "Martin KA, Mani MV, Mani A. New targets to treat obesity and the metabolic syndrome. Eur J Pharmacol. 2015;763(Pt A):64–74.",
      "volume": "763",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cmet.2011.07.015",
      "author": "KE Bornfeldt",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "issue": "5",
      "journal-title": "Cell Metab",
      "key": "239_CR4",
      "unstructured": "Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575–85.",
      "volume": "14",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.cell.2012.09.010",
      "author": "A Fedorenko",
      "doi-asserted-by": "publisher",
      "first-page": "400",
      "issue": "2",
      "journal-title": "Cell.",
      "key": "239_CR5",
      "unstructured": "Fedorenko A, Lishko PV, Kirichok Y. Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell. 2012;151(2):400–13.",
      "volume": "151",
      "year": "2012"
    },
    {
      "DOI": "10.1056/NEJMoa0810780",
      "author": "AM Cypess",
      "doi-asserted-by": "publisher",
      "first-page": "1509",
      "issue": "15",
      "journal-title": "N Engl J Med",
      "key": "239_CR6",
      "unstructured": "Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509–17.",
      "volume": "360",
      "year": "2009"
    },
    {
      "DOI": "10.1152/ajpendo.00691.2006",
      "author": "J Nedergaard",
      "doi-asserted-by": "publisher",
      "first-page": "E444",
      "issue": "2",
      "journal-title": "Am J Physiol Endocrinol Metab",
      "key": "239_CR7",
      "unstructured": "Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007;293(2):E444–52.",
      "volume": "293",
      "year": "2007"
    },
    {
      "DOI": "10.2337/db15-0146",
      "author": "MJ Betz",
      "doi-asserted-by": "publisher",
      "first-page": "2352",
      "issue": "7",
      "journal-title": "Diabetes.",
      "key": "239_CR8",
      "unstructured": "Betz MJ, Enerback S. Human brown adipose tissue: what we have learned so far. Diabetes. 2015;64(7):2352–60.",
      "volume": "64",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nm.3361",
      "author": "M Harms",
      "doi-asserted-by": "publisher",
      "first-page": "1252",
      "issue": "10",
      "journal-title": "Nat Med",
      "key": "239_CR9",
      "unstructured": "Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med. 2013;19(10):1252–63.",
      "volume": "19",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cmet.2014.12.009",
      "author": "AM Cypess",
      "doi-asserted-by": "publisher",
      "first-page": "33",
      "issue": "1",
      "journal-title": "Cell Metab",
      "key": "239_CR10",
      "unstructured": "Cypess AM, Weiner LS, Roberts-Toler C, Franquet Elia E, Kessler SH, Kahn PA, et al. Activation of human brown adipose tissue by a beta3-adrenergic receptor agonist. Cell Metab. 2015;21(1):33–8.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nm.3112",
      "author": "AM Cypess",
      "doi-asserted-by": "publisher",
      "first-page": "635",
      "issue": "5",
      "journal-title": "Nat Med",
      "key": "239_CR11",
      "unstructured": "Cypess AM, White AP, Vernochet C, Schulz TJ, Xue R, Sass CA, et al. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat Med. 2013;19(5):635–9.",
      "volume": "19",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pbio.3000412",
      "author": "S Schweizer",
      "doi-asserted-by": "publisher",
      "first-page": "e3000412-e",
      "issue": "8",
      "journal-title": "PLoS Biol",
      "key": "239_CR12",
      "unstructured": "Schweizer S, Liebisch G, Oeckl J, Hoering M, Seeliger C, Schiebel C, et al. The lipidome of primary murine white, brite, and brown adipocytes-Impact of beta-adrenergic stimulation. PLoS Biol. 2019;17(8):e3000412-e.",
      "volume": "17",
      "year": "2019"
    },
    {
      "author": "S Moosavinasab",
      "first-page": "undefined",
      "issue": "undefined",
      "journal-title": "Database",
      "key": "239_CR13",
      "unstructured": "Moosavinasab S, Patterson J, Strouse R, Rastegar-Mojarad M, Regan K, Payne PR, Huang Y, et al. ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities. Database. 2016;2016(undefined):undefined.",
      "volume": "2016",
      "year": "2016"
    },
    {
      "DOI": "10.1007/978-1-62703-721-1_11",
      "author": "H Liu",
      "doi-asserted-by": "publisher",
      "first-page": "197",
      "issue": "undefined",
      "journal-title": "Methods Mol Biol",
      "key": "239_CR14",
      "unstructured": "Liu H, Beck TN, Golemis EA, Serebriiskii IG. Integrating in silico resources to map a signaling network. Methods Mol Biol. 2014;1101(undefined):197–245.",
      "volume": "1101",
      "year": "2014"
    },
    {
      "DOI": "10.1093/bib/bbr005",
      "author": "C Andronis",
      "doi-asserted-by": "publisher",
      "first-page": "357",
      "issue": "4",
      "journal-title": "Brief Bioinform",
      "key": "239_CR15",
      "unstructured": "Andronis C, Sharma A, Virvilis V, Deftereos S, Persidis A. Literature mining, ontologies and information visualization for drug repurposing. Brief Bioinform. 2011;12(4):357–68.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1248/bpb.31.775",
      "author": "M Watanabe",
      "doi-asserted-by": "publisher",
      "first-page": "775",
      "issue": "5",
      "journal-title": "Biol Pharm Bull",
      "key": "239_CR16",
      "unstructured": "Watanabe M, Yamamoto T, Mori C, Okada N, Yamazaki N, Kajimoto K, et al. Cold-induced changes in gene expression in brown adipose tissue: implications for the activation of thermogenesis. Biol Pharm Bull. 2008;31(5):775–84.",
      "volume": "31",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s40265-018-1006-3",
      "author": "SJ Keam",
      "doi-asserted-by": "publisher",
      "first-page": "1835",
      "issue": "17",
      "journal-title": "Drugs.",
      "key": "239_CR17",
      "unstructured": "Keam SJ. Vibegron: first global approval. Drugs. 2018;78(17):1835–9.",
      "volume": "78",
      "year": "2018"
    },
    {
      "DOI": "10.1016/bs.podrm.2015.11.002",
      "author": "A Al-Majed",
      "doi-asserted-by": "publisher",
      "first-page": "379",
      "journal-title": "Profiles Drug Subst Excipients Relat Methodol",
      "key": "239_CR18",
      "unstructured": "Al-Majed A, Bakheit AH, Abdel Aziz HA, Alharbi H, Al-Jenoobi FI. Pioglitazone. Profiles Drug Subst Excipients Relat Methodol. 2016;41:379–438.",
      "volume": "41",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.dsx.2014.09.015",
      "author": "C Janani",
      "doi-asserted-by": "publisher",
      "first-page": "46",
      "issue": "1",
      "journal-title": "Diabetol Metab Syndr",
      "key": "239_CR19",
      "unstructured": "Janani C, Ranjitha Kumari BD. PPAR gamma gene--a review. Diabetol Metab Syndr. 2015;9(1):46–50.",
      "volume": "9",
      "year": "2015"
    },
    {
      "DOI": "10.1002/14651858.CD006063.pub2",
      "doi-asserted-by": "crossref",
      "key": "239_CR20",
      "unstructured": "Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Rosiglitazone for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;(3):CD006063."
    },
    {
      "DOI": "10.1016/j.jpba.2009.06.003",
      "author": "JH Lee",
      "doi-asserted-by": "publisher",
      "first-page": "872",
      "issue": "5",
      "journal-title": "J Pharm Biomed Anal",
      "key": "239_CR21",
      "unstructured": "Lee JH, Woo YA, Hwang IC, Kim CY, Kim DD, Shim CK, et al. Quantification of CKD-501, lobeglitazone, in rat plasma using a liquid-chromatography/tandem mass spectrometry method and its applications to pharmacokinetic studies. J Pharm Biomed Anal. 2009;50(5):872–7.",
      "volume": "50",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.bmc.2012.11.058",
      "author": "JP Taygerly",
      "doi-asserted-by": "publisher",
      "first-page": "979",
      "issue": "4",
      "journal-title": "Bioorg Med Chem",
      "key": "239_CR22",
      "unstructured": "Taygerly JP, McGee LR, Rubenstein SM, Houze JB, Cushing TD, Li Y, et al. Discovery of INT131: a selective PPARgamma modulator that enhances insulin sensitivity. Bioorg Med Chem. 2013;21(4):979–92.",
      "volume": "21",
      "year": "2013"
    },
    {
      "DOI": "10.1038/sj.bjp.0706745",
      "author": "PP Li",
      "doi-asserted-by": "publisher",
      "first-page": "610",
      "issue": "5",
      "journal-title": "Br J Pharmacol",
      "key": "239_CR23",
      "unstructured": "Li PP, Shan S, Chen YT, Ning ZQ, Sun SJ, Liu Q, et al. The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. Br J Pharmacol. 2006;148(5):610–8.",
      "volume": "148",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.ihj.2013.10.015",
      "author": "PC Manoria",
      "doi-asserted-by": "publisher",
      "first-page": "683",
      "issue": "6",
      "journal-title": "Indian Heart J",
      "key": "239_CR24",
      "unstructured": "Manoria PC, Chopra HK, Parashar SK, Dutta AL, Pinto B, Mullasari A, et al. The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies. Indian Heart J. 2013;65(6):683–90.",
      "volume": "65",
      "year": "2013"
    },
    {
      "DOI": "10.1002/art.39684",
      "author": "J Poiley",
      "doi-asserted-by": "publisher",
      "first-page": "2027",
      "issue": "8",
      "journal-title": "Arthritis Rheum",
      "key": "239_CR25",
      "unstructured": "Poiley J, Steinberg AS, Choi YJ, Davis CS, Martin RL, McWherter CA, et al. A randomized, double-blind, active- and placebo-controlled efficacy and safety study of arhalofenate for reducing flare in patients with gout. Arthritis Rheum. 2016;68(8):2027–34.",
      "volume": "68",
      "year": "2016"
    },
    {
      "DOI": "10.3233/JAD-151013",
      "author": "M Tong",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "issue": "1",
      "journal-title": "J Alzheimers Dis",
      "key": "239_CR26",
      "unstructured": "Tong M, Deochand C, Didsbury J, de la Monte S. T3D-959: a multi-faceted disease remedial drug candidate for the treatment of Alzheimer’s disease. J Alzheimers Dis. 2016;51(1):123–38.",
      "volume": "51",
      "year": "2016"
    },
    {
      "DOI": "10.1021/acs.jmedchem.7b01285",
      "author": "B Boubia",
      "doi-asserted-by": "publisher",
      "first-page": "2246",
      "issue": "6",
      "journal-title": "J Med Chem",
      "key": "239_CR27",
      "unstructured": "Boubia B, Poupardin O, Barth M, Binet J, Peralba P, Mounier L, et al. Design, synthesis, and evaluation of a novel series of indole sulfonamide peroxisome proliferator activated receptor (PPAR) alpha/gamma/delta triple activators: discovery of lanifibranor, a new antifibrotic clinical candidate. J Med Chem. 2018;61(6):2246–65.",
      "volume": "61",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s12974-018-1103-y",
      "author": "C Navarrete",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "issue": "1",
      "journal-title": "J Neuroinflammation",
      "key": "239_CR28",
      "unstructured": "Navarrete C, Carrillo-Salinas F, Palomares B, Mecha M, Jimenez-Jimenez C, Mestre L, et al. Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy. J Neuroinflammation. 2018;15(1):64.",
      "volume": "15",
      "year": "2018"
    },
    {
      "DOI": "10.1097/MOL.0000000000000504",
      "author": "J Heeren",
      "doi-asserted-by": "publisher",
      "first-page": "180",
      "issue": "3",
      "journal-title": "Curr Opin Lipidol",
      "key": "239_CR29",
      "unstructured": "Heeren J, Scheja L. Brown adipose tissue and lipid metabolism. Curr Opin Lipidol. 2018;29(3):180–5.",
      "volume": "29",
      "year": "2018"
    },
    {
      "DOI": "10.1161/01.CIR.102.1.21",
      "doi-asserted-by": "crossref",
      "key": "239_CR30",
      "unstructured": "Bezafibrate Infarction Prevention (BIP) study. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. Circulation. 2000;102(1):21–7."
    },
    {
      "DOI": "10.5414/CPP42212",
      "author": "J Wysocki",
      "doi-asserted-by": "publisher",
      "first-page": "212",
      "issue": "4",
      "journal-title": "Int J Clin Pharmacol Ther",
      "key": "239_CR31",
      "unstructured": "Wysocki J, Belowski D, Kalina M, Kochanski L, Okopien B, Kalina Z. Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome. Int J Clin Pharmacol Ther. 2004;42(4):212–7.",
      "volume": "42",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s11906-017-0701-x",
      "author": "SK Panchal",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "issue": "3",
      "journal-title": "Curr Hypertens Rep",
      "key": "239_CR32",
      "unstructured": "Panchal SK, Wanyonyi S, Brown L. Selenium, vanadium, and chromium as micronutrients to improve metabolic syndrome. Curr Hypertens Rep. 2017;19(3):10.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1002/mds.20124",
      "author": "W Bara-Jimenez",
      "doi-asserted-by": "publisher",
      "first-page": "1183",
      "issue": "10",
      "journal-title": "Mov Disord",
      "key": "239_CR33",
      "unstructured": "Bara-Jimenez W, Dimitrova T, Sherzai A, Favit A, Mouradian MM, Chase TN. Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson’s disease. Mov Disord. 2004;19(10):1183–6.",
      "volume": "19",
      "year": "2004"
    },
    {
      "DOI": "10.1038/oby.2008.56",
      "author": "A Astrup",
      "doi-asserted-by": "publisher",
      "first-page": "1363",
      "issue": "6",
      "journal-title": "Obesity",
      "key": "239_CR34",
      "unstructured": "Astrup A, Meier DH, Mikkelsen BO, Villumsen JS, Larsen TM. Weight loss produced by tesofensine in patients with Parkinson’s or Alzheimer’s disease. Obesity. 2008;16(6):1363–9.",
      "volume": "16",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJMoa0808949",
      "author": "KA Virtanen",
      "doi-asserted-by": "publisher",
      "first-page": "1518",
      "issue": "15",
      "journal-title": "N Engl J Med",
      "key": "239_CR35",
      "unstructured": "Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360(15):1518–25.",
      "volume": "360",
      "year": "2009"
    },
    {
      "DOI": "10.1096/fj.14-266247",
      "author": "SM Labbe",
      "doi-asserted-by": "publisher",
      "first-page": "2046",
      "issue": "5",
      "journal-title": "FASEB J",
      "key": "239_CR36",
      "unstructured": "Labbe SM, Caron A, Bakan I, Laplante M, Carpentier AC, Lecomte R, et al. In vivo measurement of energy substrate contribution to cold-induced brown adipose tissue thermogenesis. FASEB J. 2015;29(5):2046–58.",
      "volume": "29",
      "year": "2015"
    },
    {
      "DOI": "10.2337/db09-0530",
      "author": "M Saito",
      "doi-asserted-by": "publisher",
      "first-page": "1526",
      "issue": "7",
      "journal-title": "Diabetes.",
      "key": "239_CR37",
      "unstructured": "Saito M, Okamatsu-Ogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes. 2009;58(7):1526–31.",
      "volume": "58",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.tice.2016.08.001",
      "author": "TC Bargut",
      "doi-asserted-by": "publisher",
      "first-page": "452",
      "issue": "5",
      "journal-title": "Tissue Cell",
      "key": "239_CR38",
      "unstructured": "Bargut TC, Aguila MB, Mandarim-de-Lacerda CA. Brown adipose tissue: updates in cellular and molecular biology. Tissue Cell. 2016;48(5):452–60.",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.tem.2013.12.004",
      "author": "KL Townsend",
      "doi-asserted-by": "publisher",
      "first-page": "168",
      "issue": "4",
      "journal-title": "Trends Endocrinol Metab",
      "key": "239_CR39",
      "unstructured": "Townsend KL, Tseng YH. Brown fat fuel utilization and thermogenesis. Trends Endocrinol Metab. 2014;25(4):168–77.",
      "volume": "25",
      "year": "2014"
    },
    {
      "DOI": "10.1161/CIRCRESAHA.115.306647",
      "author": "G Hoeke",
      "doi-asserted-by": "publisher",
      "first-page": "173",
      "issue": "1",
      "journal-title": "Circ Res",
      "key": "239_CR40",
      "unstructured": "Hoeke G, Kooijman S, Boon MR, Rensen PC, Berbee JF. Role of brown fat in lipoprotein metabolism and atherosclerosis. Circ Res. 2016;118(1):173–82.",
      "volume": "118",
      "year": "2016"
    },
    {
      "DOI": "10.1172/JCI78362",
      "author": "L Sidossis",
      "doi-asserted-by": "publisher",
      "first-page": "478",
      "issue": "2",
      "journal-title": "J Clin Invest",
      "key": "239_CR41",
      "unstructured": "Sidossis L, Kajimura S. Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis. J Clin Invest. 2015;125(2):478–86.",
      "volume": "125",
      "year": "2015"
    },
    {
      "DOI": "10.1146/annurev-physiol-021115-105339",
      "author": "FM Fisher",
      "doi-asserted-by": "publisher",
      "first-page": "223",
      "journal-title": "Annu Rev Physiol",
      "key": "239_CR42",
      "unstructured": "Fisher FM, Maratos-Flier E. Understanding the physiology of FGF21. Annu Rev Physiol. 2016;78:223–41.",
      "volume": "78",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nm.3713",
      "author": "GX Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1436",
      "issue": "12",
      "journal-title": "Nat Med",
      "key": "239_CR43",
      "unstructured": "Wang GX, Zhao XY, Meng ZX, Kern M, Dietrich A, Chen Z, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med. 2014;20(12):1436–43.",
      "volume": "20",
      "year": "2014"
    },
    {
      "DOI": "10.1042/CS20150339",
      "author": "L Poekes",
      "doi-asserted-by": "publisher",
      "first-page": "933",
      "issue": "11",
      "journal-title": "Clin Sci",
      "key": "239_CR44",
      "unstructured": "Poekes L, Lanthier N, Leclercq IA. Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome. Clin Sci. 2015;129(11):933–49.",
      "volume": "129",
      "year": "2015"
    },
    {
      "DOI": "10.1093/ajcn/55.1.252s",
      "author": "MA Cawthorne",
      "doi-asserted-by": "publisher",
      "first-page": "252s",
      "issue": "1 Suppl",
      "journal-title": "Am J Clin Nutr",
      "key": "239_CR45",
      "unstructured": "Cawthorne MA, Sennitt MV, Arch JR, Smith SA. BRL 35135, a potent and selective atypical beta-adrenoceptor agonist. Am J Clin Nutr. 1992;55(1 Suppl):252s–7s.",
      "volume": "55",
      "year": "1992"
    },
    {
      "DOI": "10.2337/diabetes.47.10.1555",
      "author": "C Weyer",
      "doi-asserted-by": "publisher",
      "first-page": "1555",
      "issue": "10",
      "journal-title": "Diabetes.",
      "key": "239_CR46",
      "unstructured": "Weyer C, Tataranni PA, Snitker S, Danforth E Jr, Ravussin E. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Diabetes. 1998;47(10):1555–61.",
      "volume": "47",
      "year": "1998"
    },
    {
      "DOI": "10.1093/ajcn/76.4.780",
      "author": "TM Larsen",
      "doi-asserted-by": "publisher",
      "first-page": "780",
      "issue": "4",
      "journal-title": "Am J Clin Nutr",
      "key": "239_CR47",
      "unstructured": "Larsen TM, Toubro S, van Baak MA, Gottesdiener KM, Larson P, Saris WH, et al. Effect of a 28-d treatment with L-796568, a novel beta (3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am J Clin Nutr. 2002;76(4):780–8.",
      "volume": "76",
      "year": "2002"
    },
    {
      "DOI": "10.1210/jc.2006-1740",
      "author": "LM Redman",
      "doi-asserted-by": "publisher",
      "first-page": "527",
      "issue": "2",
      "journal-title": "J Clin Endocrinol Metab",
      "key": "239_CR48",
      "unstructured": "Redman LM, de Jonge L, Fang X, Gamlin B, Recker D, Greenway FL, et al. Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study. J Clin Endocrinol Metab. 2007;92(2):527–31.",
      "volume": "92",
      "year": "2007"
    },
    {
      "DOI": "10.1177/2042018811398517",
      "author": "JR Arch",
      "doi-asserted-by": "publisher",
      "first-page": "59",
      "issue": "2",
      "journal-title": "Ther Adv Endocrinol Metab",
      "key": "239_CR49",
      "unstructured": "Arch JR. Challenges in beta (3)-adrenoceptor agonist drug development. Ther Adv Endocrinol Metab. 2011;2(2):59–64.",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1038/clpt.2012.181",
      "author": "M Malik",
      "doi-asserted-by": "publisher",
      "first-page": "696",
      "issue": "6",
      "journal-title": "Clin Pharmacol Ther",
      "key": "239_CR50",
      "unstructured": "Malik M, van Gelderen EM, Lee JH, Kowalski DL, Yen M, Goldwater R, et al. Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study. Clin Pharmacol Ther. 2012;92(6):696–706.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1177/1756287212457114",
      "author": "E Sacco",
      "doi-asserted-by": "publisher",
      "first-page": "315",
      "issue": "6",
      "journal-title": "Ther Adv Urol",
      "key": "239_CR51",
      "unstructured": "Sacco E, Bientinesi R. Mirabegron: a review of recent data and its prospects in the management of overactive bladder. Ther Adv Urol. 2012;4(6):315–24.",
      "volume": "4",
      "year": "2012"
    },
    {
      "DOI": "10.1124/jpet.106.115840",
      "author": "T Takasu",
      "doi-asserted-by": "publisher",
      "first-page": "642",
      "issue": "2",
      "journal-title": "J Pharmacol Exp Ther",
      "key": "239_CR52",
      "unstructured": "Takasu T, Ukai M, Sato S, Matsui T, Nagase I, Maruyama T, et al. Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther. 2007;321(2):642–7.",
      "volume": "321",
      "year": "2007"
    },
    {
      "DOI": "10.2337/db18-0462",
      "author": "AS Baskin",
      "doi-asserted-by": "publisher",
      "first-page": "2113",
      "issue": "10",
      "journal-title": "Diabetes.",
      "key": "239_CR53",
      "unstructured": "Baskin AS, Linderman JD, Brychta RJ, McGehee S, Anflick-Chames E, Cero C, et al. Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a beta3-adrenergic receptor agonist. Diabetes. 2018;67(10):2113–25.",
      "volume": "67",
      "year": "2018"
    },
    {
      "DOI": "10.1172/jci.insight.121510",
      "author": "BS Finlin",
      "doi-asserted-by": "publisher",
      "first-page": "e121510",
      "issue": "15",
      "journal-title": "JCI Insight",
      "key": "239_CR54",
      "unstructured": "Finlin BS, Memetimin H, Confides AL, Kasza I, Zhu B, Vekaria HJ, et al. Human adipose beiging in response to cold and mirabegron. JCI Insight. 2018;3(15):e121510.",
      "volume": "3",
      "year": "2018"
    },
    {
      "DOI": "10.1128/MCB.25.13.5466-5479.2005",
      "author": "J Robidoux",
      "doi-asserted-by": "publisher",
      "first-page": "5466",
      "issue": "13",
      "journal-title": "Mol Cell Biol",
      "key": "239_CR55",
      "unstructured": "Robidoux J, Cao W, Quan H, Daniel KW, Moukdar F, Bai X, et al. Selective activation of mitogen-activated protein (MAP) kinase kinase 3 and p38alpha MAP kinase is essential for cyclic AMP-dependent UCP1 expression in adipocytes. Mol Cell Biol. 2005;25(13):5466–79.",
      "volume": "25",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nature10777",
      "author": "P Bostrom",
      "doi-asserted-by": "publisher",
      "first-page": "463",
      "issue": "7382",
      "journal-title": "Nature.",
      "key": "239_CR56",
      "unstructured": "Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463–8.",
      "volume": "481",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature08262",
      "author": "S Kajimura",
      "doi-asserted-by": "publisher",
      "first-page": "1154",
      "issue": "7259",
      "journal-title": "Nature.",
      "key": "239_CR57",
      "unstructured": "Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature. 2009;460(7259):1154–8.",
      "volume": "460",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.bbamcr.2013.12.018",
      "author": "JC Lin",
      "doi-asserted-by": "publisher",
      "first-page": "769",
      "issue": "4",
      "journal-title": "Biochim Biophys Acta",
      "key": "239_CR58",
      "unstructured": "Lin JC, Tarn WY, Hsieh WK. Emerging role for RNA binding motif protein 4 in the development of brown adipocytes. Biochim Biophys Acta. 2014;1843(4):769–79.",
      "volume": "1843",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nm1025",
      "author": "RM Evans",
      "doi-asserted-by": "publisher",
      "first-page": "355",
      "issue": "4",
      "journal-title": "Nat Med",
      "key": "239_CR59",
      "unstructured": "Evans RM, Barish GD, Wang YX. PPARs and the complex journey to obesity. Nat Med. 2004;10(4):355–61.",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.cmet.2012.01.019",
      "author": "H Ohno",
      "doi-asserted-by": "publisher",
      "first-page": "395",
      "issue": "3",
      "journal-title": "Cell Metab",
      "key": "239_CR60",
      "unstructured": "Ohno H, Shinoda K, Spiegelman BM, Kajimura S. PPARgamma agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab. 2012;15(3):395–404.",
      "volume": "15",
      "year": "2012"
    },
    {
      "DOI": "10.2217/fca-2016-0059",
      "author": "L Han",
      "doi-asserted-by": "publisher",
      "first-page": "259",
      "issue": "3",
      "journal-title": "Futur Cardiol",
      "key": "239_CR61",
      "unstructured": "Han L, Shen WJ, Bittner S, Kraemer FB, Azhar S. PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-alpha. Futur Cardiol. 2017;13(3):259–78.",
      "volume": "13",
      "year": "2017"
    },
    {
      "DOI": "10.1038/sj.bjp.0707539",
      "author": "T Lehr",
      "doi-asserted-by": "publisher",
      "first-page": "164",
      "issue": "1",
      "journal-title": "Br J Pharmacol",
      "key": "239_CR62",
      "unstructured": "Lehr T, Staab A, Tillmann C, Nielsen EO, Trommeshauser D, Schaefer HG, et al. Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach. Br J Pharmacol. 2008;153(1):164–74.",
      "volume": "153",
      "year": "2008"
    },
    {
      "DOI": "10.1517/13543780902967632",
      "author": "SA Doggrell",
      "doi-asserted-by": "publisher",
      "first-page": "1043",
      "issue": "7",
      "journal-title": "Expert Opin Investig Drugs",
      "key": "239_CR63",
      "unstructured": "Doggrell SA. Tesofensine--a novel potent weight loss medicine. Evaluation of: Astrup A, Breum L, Jensen TJ, Kroustrup JP, Larsen TM. Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1906-13. Expert Opin Investig Drugs. 2009;18(7):1043–6.",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ijo.2010.87",
      "author": "A Sjodin",
      "doi-asserted-by": "publisher",
      "first-page": "1634",
      "issue": "11",
      "journal-title": "Int J Obes",
      "key": "239_CR64",
      "unstructured": "Sjodin A, Gasteyger C, Nielsen AL, Raben A, Mikkelsen JD, Jensen JK, et al. The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men. Int J Obes. 2010;34(11):1634–43.",
      "volume": "34",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.euroneuro.2013.10.007",
      "author": "L Appel",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "issue": "2",
      "journal-title": "Eur Neuropsychopharmacol",
      "key": "239_CR65",
      "unstructured": "Appel L, Bergstrom M, Buus Lassen J, Langstrom B. Tesofensine, a novel triple monoamine re-uptake inhibitor with anti-obesity effects: dopamine transporter occupancy as measured by PET. Eur Neuropsychopharmacol. 2014;24(2):251–61.",
      "volume": "24",
      "year": "2014"
    },
    {
      "key": "239_CR66",
      "unstructured": "Pubmed2ensembl. http://pubmed2ensembl.ls.manchester.ac.uk/ . Accessed 1 Dec 2018."
    },
    {
      "DOI": "10.1371/journal.pone.0024716",
      "author": "J Baran",
      "doi-asserted-by": "publisher",
      "first-page": "e24716",
      "issue": "9",
      "journal-title": "PLoS One",
      "key": "239_CR67",
      "unstructured": "Baran J, Gerner M, Haeussler M, Nenadic G, Bergman CM. pubmed2ensembl: a resource for mining the biological literature on genes. PLoS One. 2011;6(9):e24716.",
      "volume": "6",
      "year": "2011"
    },
    {
      "key": "239_CR68",
      "unstructured": "GeneCodis. http://genecodis.cnb.csic.es/ . Accessed 3 Dec 2018."
    },
    {
      "DOI": "10.1093/nar/gks402",
      "author": "D Tabas-Madrid",
      "doi-asserted-by": "publisher",
      "first-page": "W478",
      "issue": "Web Server issu",
      "journal-title": "Nucleic Acids Res",
      "key": "239_CR69",
      "unstructured": "Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A. GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res. 2012;40(Web Server issue):W478–83.",
      "volume": "40",
      "year": "2012"
    },
    {
      "DOI": "10.1186/gb-2007-8-1-r3",
      "author": "P Carmona-Saez",
      "doi-asserted-by": "publisher",
      "first-page": "R3",
      "issue": "1",
      "journal-title": "Genome Biol",
      "key": "239_CR70",
      "unstructured": "Carmona-Saez P, Chagoyen M, Tirado F, Carazo JM, Pascual-Montano A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 2007;8(1):R3.",
      "volume": "8",
      "year": "2007"
    },
    {
      "key": "239_CR71",
      "unstructured": "STRING. http://string-db.org/ . Accessed 5 Dec 2018."
    },
    {
      "DOI": "10.1093/nar/gku1003",
      "author": "D Szklarczyk",
      "doi-asserted-by": "publisher",
      "first-page": "D447",
      "issue": "Database issue",
      "journal-title": "Nucleic Acids Res",
      "key": "239_CR72",
      "unstructured": "Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–52.",
      "volume": "43",
      "year": "2015"
    },
    {
      "DOI": "10.1002/0471250953.bi0813s47",
      "author": "G Su",
      "doi-asserted-by": "publisher",
      "first-page": "8.13.1",
      "journal-title": "Curr Protoc Bioinformatics",
      "key": "239_CR73",
      "unstructured": "Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014;47:8.13.1–24.",
      "volume": "47",
      "year": "2014"
    },
    {
      "key": "239_CR74",
      "unstructured": "The Human Protein Atlas. https://www.proteinatlas.org/ . Accessed 1 Jan 2019."
    },
    {
      "DOI": "10.1126/science.1260419",
      "author": "M Uhlén",
      "doi-asserted-by": "publisher",
      "first-page": "1260419",
      "issue": "6220",
      "journal-title": "Science",
      "key": "239_CR75",
      "unstructured": "Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.",
      "volume": "347",
      "year": "2015"
    },
    {
      "key": "239_CR76",
      "unstructured": "PharmaProjects. https://pharmaintelligence.informa.com/ . Accessed 1 Jan 2019."
    },
    {
      "DOI": "10.1016/j.ctrv.2016.10.009",
      "author": "DL Jardim",
      "doi-asserted-by": "publisher",
      "first-page": "12",
      "journal-title": "Cancer Treat Rev",
      "key": "239_CR77",
      "unstructured": "Jardim DL, Groves ES, Breitfeld PP, Kurzrock R. Factors associated with failure of oncology drugs in late-stage clinical development: a systematic review. Cancer Treat Rev. 2017;52:12–21.",
      "volume": "52",
      "year": "2017"
    }
  ],
  "reference-count": 77,
  "references-count": 77,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-019-0239-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Identification of key candidate genes and molecular pathways in white fat browning: an anti-obesity drug discovery based on computational biology"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}